The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of RX-3117, an oral agent activated by uridine cytidine kinase 2, to treat subjects with advanced solid tumors.
 
Drew Warren Rasco
Research Funding - Celgene (Inst); Daiichi Sankyo (Inst); Five Prime Therapeutics (Inst); Millennium (Inst); Rexahn Pharmaceuticals (Inst); Santa Maria Biotherapeutics (Inst); Teva (Inst)
 
Amita Patnaik
Research Funding - Rexahn Pharmaceuticals (Inst)
 
Anthony W. Tolcher
Stock and Other Ownership Interests - Symphony Evolution
Consulting or Advisory Role - AbbVie; Adnexus; Ambit BioSciences; AP Pharma; Aragon Pharmaceuticals; ARIAD; ArQule; Asana Biosciences; Astellas Pharma; Astex Pharmaceuticals; AVID Radiopharmaceuticals; Bayer Schering Pharma; Bind Therapeutics; BioMed Valley Discoveries; Blend Therapeutics; Bristol-Myers Squibb; Celator; Clovis Oncology; Curis; Dicerna; Eisai; Emergent BioSolutions; Heron; Janssen; Johnson & Johnson; Lilly; MedImmune; Merck Sharp & Dohme; Merus; Micromet; Nanobiotix; Nektar; Neumedicines; Novartis (I); Oncogenex; Pfizer; Pharmacyclics; Pierre Fabre; ProNAi; Proximagen; Symphony Evolution; Vaccinex; Valent Technologies; Zyngenia; Zyngenia
 
Kyriakos P. Papadopoulos
Research Funding - Abbvie (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Medimmune (Inst); Novartis (Inst); Onyx (Inst); Sanofi (Inst)
 
Christine Peterson
Employment - Rexahn Pharmaceuticals
Stock and Other Ownership Interests - Rexahn Pharmaceuticals
 
Ely Benaim
Employment - Rexahn Pharmaceuticals
Leadership - Rexahn Pharmaceuticals
Stock and Other Ownership Interests - Rexahn Pharmaceuticals